TP53 and neoplasm: Taken together, above results show that the heterozygous p53* mutant promotes tumour growth, with a modest effect on CNA, whereas p53* combined with loss of the second p53 allele in the setting of low dose mutagen exposure increases the number of tumours and results in marked chromosomal instability both in normal epithelia and in tumours.